Total Funding
23
61
Total FundingEquity Crowdfunding raised
Growth Score
-8 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
174785
BioClonetics is a biotechnology company.
Ed connaghan: CEO
About the Company
BioClonetics is a biotechnology company. They develop biotech drugs from monoclonal antibodies. They produce human monoclonal antibodies that target and neutralise infectious diseases including HIV, influenza, tetanus, and diphtheria.
